
EPOK Therapeutics
Operator of a clinical-stage biopharmaceutical company intended to develop novel antibody-based therapeutics for the treatment of metabolic diseases. The company's lead product candidate is an antibod...
Valuation
$0
Share Price
N/A
Total Raised
$6.7M
Last Round
N/A